A piece of news reached Sarah Gilbert a few days back. She is the same who has developed a coronavirus vaccine. She received news about her medication, which she developed with the help of AstraZeneca has been working well on covid patients. With this news, another update also reached her. The update was that the professor of Oxford wanted an identification code, about the effectiveness of the vaccine.
When her fellow worker Andrew Pollard called her with the results. He wanted to reveal slides but numbers. The statement says “I didn’t really understand why we would have to go through slides,” she recalled. “But then it became clear because it’s rather more complicated in our trial.”
That twist brought a spiral in the race close by Pfizer Inc. and Moderna Inc., which are other vaccines trying to end the deadly virus. Now the question rising is relate to the most effective vaccine and it’s well-being, it has raised a few doubts, whether the U.S Drug Administration will limpid.
Talking about the vaccine results, Oxford university has come up with results of 131 reports. 70% of the result is on the positive side, and only 50% standard has been set by the Food and Drug Administration for corona vaccines.
A study has also found 16 acute covid cases, and all of them were people who didn’t consume AstraZeneca’s vaccine. Good news came up for AstraZeneca that, the vaccine has been approved in the U.S for 6-week trials, but the company didn’t provide proper details.
Bemuse for the AstraZeneca vaccine is that when the dose was high the medicine didn’t affect much and only reached 62% of results. But when the vaccine was provided with a half dose, the number of positive results rose to 90%.
When Gilbert was asked about her reaction she stated “I was surprised,” “I really hadn’t expected that.”